Last 26 quarters of trend data · Healthcare · Healthcare Software & Telehealth
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '27 | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 43.70 | 39.36 | 39.88 | 58.25 | 35.71 | 58.99 | 56.80 | 46.80 | 36.07 | 49.51 | 33.30 | 33.64 | 29.21 | 35.37 | 65.42 | 57.82 | 52.44 | 62.96 | 87.05 | 76.60 | 48.20 |
| — | -33.3% | -29.8% | +24.5% | -1.0% | +19.1% | +70.6% | +39.1% | +23.5% | +40.0% | -49.1% | -41.8% | -44.3% | -43.8% | -24.8% | -24.5% | +8.8% | -46.9% | -65.3% | — | — | |
| P/S Ratio | 9.19 | 7.62 | 6.33 | 7.81 | 11.92 | 21.78 | 21.14 | 21.29 | 16.01 | 15.95 | 11.00 | 11.46 | 10.39 | 9.76 | 16.65 | 15.52 | 15.44 | 15.82 | 20.64 | 30.02 | 27.71 |
| — | -65.0% | -70.1% | -63.3% | -25.6% | +36.5% | +92.2% | +85.8% | +54.1% | +63.5% | -34.0% | -26.2% | -32.7% | -38.3% | -19.3% | -48.3% | -44.3% | -71.3% | -47.8% | — | — | |
| P/B Ratio | 6.81 | 5.73 | 4.33 | 4.78 | 9.01 | 13.40 | 12.03 | 10.88 | 10.47 | 9.08 | 6.10 | 6.00 | 6.50 | 5.09 | 7.29 | 7.13 | 7.65 | 7.36 | 8.30 | 12.80 | 12.93 |
| — | -57.2% | -64.0% | -56.1% | -14.0% | +47.6% | +97.3% | +81.2% | +61.1% | +78.5% | -16.3% | -15.8% | -15.0% | -30.8% | -12.1% | -44.3% | -40.8% | -67.5% | -47.4% | — | — | |
| P/FCF | 20.33 | 14.57 | 23.64 | 10.59 | 37.69 | 40.09 | 51.30 | 30.37 | 42.56 | 32.68 | 35.23 | 21.71 | 28.84 | 95.43 | 32.46 | 37.76 | 37.47 | 42.88 | 43.90 | 62.67 | 105.90 |
| — | -63.7% | -53.9% | -65.1% | -11.5% | +22.7% | +45.6% | +39.8% | +47.6% | -65.8% | +8.5% | -42.5% | -23.0% | +122.6% | -26.0% | -39.8% | -64.6% | -82.3% | -50.5% | — | — | |
| EV / EBITDA | 30.73 | 26.48 | 24.39 | 37.43 | 28.88 | 54.08 | 53.28 | 56.21 | 32.23 | 38.39 | 28.15 | 30.01 | 22.57 | 29.82 | 53.68 | 47.44 | 42.56 | 46.18 | 76.78 | 95.02 | 72.44 |
| — | -51.0% | -54.2% | -33.4% | -10.4% | +40.9% | +89.2% | +87.3% | +42.8% | +28.7% | -47.6% | -36.7% | -47.0% | -35.4% | -30.1% | -50.1% | -41.3% | -72.3% | -26.7% | — | — | |
| EV / EBIT | 27.32 | 25.40 | 22.92 | 33.74 | 27.13 | 49.79 | 47.60 | 49.59 | 29.62 | 38.60 | 25.74 | 27.79 | 23.54 | 26.01 | 58.39 | 51.35 | 45.45 | 49.90 | 85.17 | 99.68 | 75.19 |
| — | -49.0% | -51.8% | -32.0% | -8.4% | +29.0% | +84.9% | +78.5% | +25.8% | +48.4% | -55.9% | -45.9% | -48.2% | -47.9% | -31.4% | -48.5% | -39.6% | -71.4% | -22.2% | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '27 | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.1% | 85.5% | 84.9% | 86.7% | 89.9% | 90.3% | 89.2% | 89.5% | 91.6% | 90.0% | 89.3% | 89.4% | 91.0% | 88.8% | 87.9% | 87.7% | 88.3% | 87.1% | 85.6% | 87.4% | 88.7% |
| — | -5.3% | -4.8% | -3.2% | -1.9% | +0.3% | -0.1% | +0.2% | +0.7% | +1.4% | +1.6% | +1.9% | +3.1% | +1.9% | +2.7% | +0.3% | -0.5% | -1.9% | -3.9% | -0.7% | +2.4% | |
| Operating Margin | 33.3% | 25.2% | 21.5% | 17.1% | 38.9% | 37.8% | 37.4% | 35.2% | 47.4% | 38.8% | 36.4% | 35.5% | 43.3% | 29.7% | 27.4% | 29.6% | 33.4% | 31.4% | 23.9% | 29.8% | 36.6% |
| — | -33.4% | -42.5% | -51.5% | -18.0% | -2.7% | +2.8% | -0.7% | +9.5% | +30.6% | +32.9% | +19.8% | +29.6% | -5.3% | +14.4% | -0.7% | -8.7% | -0.1% | -30.1% | -13.0% | +19.7% | |
| Net Margin | 30.4% | 19.9% | 15.5% | 13.1% | 33.3% | 36.8% | 36.5% | 45.2% | 44.6% | 32.3% | 32.7% | 34.4% | 35.4% | 26.9% | 26.2% | 27.6% | 29.0% | 25.7% | 24.7% | 39.2% | 56.9% |
| — | -46.0% | -57.5% | -70.9% | -25.4% | +14.1% | +11.9% | +31.3% | +25.8% | +19.8% | +24.7% | +24.5% | +22.1% | +4.7% | +6.0% | -29.5% | -48.9% | -43.4% | -31.8% | +21.7% | +93.7% |
| Metric | TTM | Q2 '27 | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 19.3% | 3.8% | 2.6% | 2.0% | 5.9% | 5.9% | 5.1% | 5.9% | 7.5% | 4.7% | 4.6% | 4.6% | 5.5% | 3.3% | 2.9% | 3.2% | 3.7% | 3.0% | 2.5% | 4.3% | 6.9% |
| — | -35.6% | -48.5% | -66.5% | -21.4% | +24.2% | +10.9% | +28.5% | +36.6% | +43.3% | +57.1% | +42.2% | +49.3% | +11.3% | +15.5% | -24.4% | -46.4% | -38.6% | -62.0% | -81.3% | -51.4% | |
| ROA | 16.4% | 3.2% | 2.2% | 1.7% | 5.1% | 5.0% | 4.3% | 5.1% | 6.6% | 4.0% | 3.8% | 3.9% | 4.7% | 2.8% | 2.5% | 2.8% | 3.2% | 2.5% | 2.2% | 3.8% | 6.2% |
| — | -36.7% | -49.0% | -67.3% | -22.3% | +25.2% | +12.4% | +31.3% | +38.7% | +43.4% | +55.0% | +40.3% | +48.2% | +11.0% | +13.2% | -27.1% | -48.3% | -40.4% | -55.0% | -59.3% | -26.0% | |
| ROIC | 19.8% | 4.8% | 3.6% | 2.2% | 5.8% | 5.2% | 4.6% | 4.1% | 7.2% | 5.0% | 4.2% | 4.0% | 5.7% | 3.4% | 2.9% | 3.0% | 3.5% | 3.0% | 2.1% | 2.8% | 3.7% |
| — | -7.6% | -21.0% | -46.0% | -19.4% | +4.8% | +8.4% | +3.9% | +25.5% | +44.7% | +44.5% | +32.1% | +61.6% | +15.7% | +41.2% | +9.6% | -4.4% | -34.4% | -92.4% | -95.6% | -85.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '27 | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.00 | 0.00 |
| — | -4.2% | -8.5% | -6.4% | -13.0% | -26.7% | -24.8% | -29.0% | -27.9% | -18.7% | -2.7% | -0.3% | +3.6% | -2.9% | +21.0% | +1206.3% | +784.4% | +2132.2% | +1112.4% | -93.4% | -87.2% | |
| Debt / EBITDA | 0.04 | 0.19 | 0.26 | 0.35 | 0.14 | 0.17 | 0.21 | 0.24 | 0.16 | 0.24 | 0.29 | 0.33 | 0.25 | 0.41 | 0.48 | 0.44 | 0.38 | 0.45 | 0.49 | 0.04 | 0.04 |
| — | +12.9% | +23.4% | +46.2% | -10.1% | -30.6% | -28.4% | -26.5% | -36.4% | -41.5% | -40.4% | -25.5% | -35.2% | -8.2% | -1.0% | +1083.1% | +786.3% | +1810.7% | +1524.5% | -29.3% | -54.7% | |
| Current Ratio | 6.09 | 6.37 | 6.08 | 6.09 | 6.63 | 7.79 | 6.47 | 6.97 | 8.74 | 7.24 | 6.72 | 6.20 | 8.03 | 7.00 | 7.46 | 6.99 | 8.49 | 7.18 | 7.24 | 8.12 | 9.36 |
| — | -18.1% | -6.0% | -12.5% | -24.1% | +7.5% | -3.7% | +12.4% | +8.9% | +3.4% | -10.0% | -11.3% | -5.4% | -2.4% | +3.0% | -13.9% | -9.3% | -17.3% | -8.3% | +295.9% | +374.7% | |
| Quick Ratio | 6.09 | 6.37 | 6.08 | 6.09 | 6.63 | 7.79 | 6.47 | 6.97 | 8.74 | 7.24 | 6.72 | 6.20 | 8.03 | 7.00 | 7.46 | 6.99 | 8.49 | 7.18 | 7.24 | 8.12 | 9.30 |
| — | -18.1% | -6.0% | -12.5% | -24.1% | +7.5% | -3.7% | +12.4% | +8.9% | +3.4% | -10.0% | -11.3% | -5.4% | -2.4% | +3.0% | -13.9% | -8.8% | -17.3% | -8.3% | +295.9% | +371.9% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 26 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying DOCS stock.
Doximity, Inc.'s current P/E is 43.7x. The average P/E over the last 4 quarters is 43.3x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Doximity, Inc.'s current operating margin is 33.3%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Doximity, Inc.'s business trajectory between earnings reports.